CELLLIGHT
LIVE

Serial Number

79359775

Owner

Luminous Labs GmbH

Attorney

Elizabeth Baio

Filing Date

Aug 24, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CELLLIGHT Trademark

Serial Number: 79359775 • Registration: 7410737

CELLLIGHT is a trademark filed by Luminous Labs GmbH on August 24, 2022. The trademark is classified under Class 10 (Medical Apparatus), Class 11 (Environmental Control), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Luminous Labs GmbH

Lazarettgürtel 54 422

Entity Type: 27

Trademark Details

Filing Date

August 24, 2022

Registration Date

June 11, 2024

Published for Opposition

March 26, 2024

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 14, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 21, 2024 FICS
FINAL DISPOSITION PROCESSED
Nov 21, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 11, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 11, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 11, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 7, 2024 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 26, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 6, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 6, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 19, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 18, 2024 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 4, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 4, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 28, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jun 27, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 12, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 13, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 9, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 5, 2023 REPR